Francesca Vendemini

MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia

Annalisa Astolfi, Francesca Vendemini, Milena Urbini et al. · Oncotarget · 2013 · 33 citations · Full text

Medicine, Molecular Biology, Oncology +17

Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis

Riccardo Masetti, Francesco Baccelli, Davide Leardini et al. · Blood Advances · 2023 · 33 citations · Full text

Medicine, Oncology, Pediatrics +9

Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children

Riccardo Masetti, Francesca Vendemini, Paola Quarello et al. · Pediatric Blood & Cancer · 2020 · 31 citations

Medicine, Hematology, Pharmacotherapy +14

Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late‐onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients

Daniele Zama, Riccardo Masetti, Francesca Vendemini et al. · Pediatric Transplantation · 2012 · 29 citations

Medicine, Hematology, Pediatrics +11

Mutations of <i>SETBP1</i> and <i>JAK3</i> in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group

Silvia Bresolin, Paola De Filippi, Francesca Vendemini et al. · Oncotarget · 2016 · 22 citations · Full text

Medicine, Hematology, Oncology +17